Urinary retention and Mobility decreased

Summary:

Mobility decreased is found among people with Urinary retention, especially for people who are female, 40-49 old.

The study analyzes which people have Mobility decreased with Urinary retention. It is created by eHealthMe based on reports of 33 people who have Urinary retention from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Urinary retention?

Urinary retention (the inability to completely or partially empty the bladder) is found to be associated with 1,570 drugs and 1,737 conditions by eHealthMe. Check the latest studies of Urinary retention.

What is Mobility decreased?

Mobility decreased (ability to move is reduced) is found to be associated with 1,778 drugs and 1,632 conditions by eHealthMe. Check the latest studies of Mobility decreased.

On Jul, 09, 2026

33 people who have Urinary Retention and Mobility Decreased are studied.

Would you have Mobility decreased when you have Urinary retention?

Gender of people who have Urinary Retention and experienced Mobility Decreased *:

female: 51.52 %
male: 48.48 %

Age of people who have Urinary Retention and experienced Mobility Decreased *:

Common co-existing conditions for these people *:

Anaemia (lack of blood): 17 people, 51.52%
High Blood Pressure: 11 people, 33.33%
Pain: 10 people, 30.30%
Multiple Myeloma (cancer of the plasma cells): 8 people, 24.24%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 8 people, 24.24%
Chronic Kidney Disease: 7 people, 21.21%
Osteoporosis (bones weak and more likely to break): 5 people, 15.15%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 5 people, 15.15%
Neuralgia (pain in one or more nerves): 5 people, 15.15%
Insomnia (sleeplessness): 4 people, 12.12%

Common drugs taken by these people *:

Common symptoms for these people *:

Fall: 16 people, 48.48%
Urticaria (rash of round, red welts on the skin that itch intensely): 11 people, 33.33%
Neuropathy Peripheral (surface nerve damage): 11 people, 33.33%
Fatigue (feeling of tiredness): 11 people, 33.33%
Itching: 10 people, 30.30%
Vaginal Infection: 10 people, 30.30%
Gait Disturbance: 10 people, 30.30%
Feeling Cold: 10 people, 30.30%
Osteitis (a general term for inflammation of bone): 10 people, 30.30%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 10 people, 30.30%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Mobility decreased?

- Check whether Mobility decreased is associated with a drug or a condition

Related publications that referenced our studies

Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .

Related studies:

Treatments, associated drugs and conditions:

Urinary retention (42,974 reports)
Mobility decreased (83,538 reports)

All the drugs that are associated with Mobility decreased:

Mobility decreased (1,778 drugs)

All the conditions that are associated with Mobility decreased:

Mobility decreased (1,632 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Mobility decreased and Urinary retention, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.